Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.1.9
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents [note 5] $ 27,897us-gaap_CashAndCashEquivalentsAtCarryingValue $ 14,593us-gaap_CashAndCashEquivalentsAtCarryingValue
Restricted cash [note 5] 251us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue  
Short-term investments [note 5] 19,160us-gaap_ShortTermInvestments 24,629us-gaap_ShortTermInvestments
Interest receivable 113us-gaap_InterestReceivableCurrent 218us-gaap_InterestReceivableCurrent
Amounts receivable 5,676us-gaap_AccountsReceivableNetCurrent 8,657us-gaap_AccountsReceivableNetCurrent
Prepaid expenses 2,165us-gaap_PrepaidExpenseAndOtherAssetsCurrent 5,770us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Other current assets [note 8] 499us-gaap_OtherAssetsCurrent  
Total current assets 55,761us-gaap_AssetsCurrent 53,867us-gaap_AssetsCurrent
Restricted cash [note 5]   314us-gaap_RestrictedCashAndCashEquivalentsNoncurrent
Property and equipment, net [note 6] 257us-gaap_PropertyPlantAndEquipmentNet 397us-gaap_PropertyPlantAndEquipmentNet
Other assets [note 8] 273us-gaap_OtherAssetsNoncurrent 1,111us-gaap_OtherAssetsNoncurrent
Total assets 56,291us-gaap_Assets 55,689us-gaap_Assets
Current liabilities:    
Accounts payable 72us-gaap_AccountsPayableCurrent 139us-gaap_AccountsPayableCurrent
Accrued liabilities other 863us-gaap_OtherAccruedLiabilitiesCurrent 500us-gaap_OtherAccruedLiabilitiesCurrent
Accrued clinical liabilities 13,462ogxi_AccruedLiabilitiesClinicalCurrent 11,284ogxi_AccruedLiabilitiesClinicalCurrent
Accrued compensation 1,333us-gaap_EmployeeRelatedLiabilitiesCurrent 1,705us-gaap_EmployeeRelatedLiabilitiesCurrent
Current portion of long-term obligations [note 7 and note 15] 236us-gaap_CapitalLeaseObligationsCurrent 1,092us-gaap_CapitalLeaseObligationsCurrent
Lease termination liability [note 15] 3,250ogxi_LeaseTerminationLiabilityCurrent  
Warrant liability [note 5 and note 11] 3,002us-gaap_WarrantsAndRightsOutstanding 214us-gaap_WarrantsAndRightsOutstanding
Total current liabilities 22,218us-gaap_LiabilitiesCurrent 14,934us-gaap_LiabilitiesCurrent
Long-term obligations, less current portion [note 7 and note 15] 14us-gaap_CapitalLeaseObligationsNoncurrent 3,544us-gaap_CapitalLeaseObligationsNoncurrent
Total liabilities 22,232us-gaap_Liabilities 18,478us-gaap_Liabilities
Commitments and contingencies [note 13 and note 15]      
Stockholders' equity:    
Common stock, $0.001 par value, 50,000,000 shares authorized, 22,630,652 and 14,707,886 issued at December 31, 2014 and December 31, 2013, respectively, and 22,621,426 and 14,707,886 outstanding at December 31, 2014 and December 31, 2013, respectively 22us-gaap_CommonStockValue 15us-gaap_CommonStockValue
Additional paid-in capital 191,373us-gaap_AdditionalPaidInCapitalCommonStock 168,242us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated deficit (159,958)us-gaap_RetainedEarningsAccumulatedDeficit (133,689)us-gaap_RetainedEarningsAccumulatedDeficit
Accumulated other comprehensive income 2,622us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax 2,643us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Total stockholders’ equity 34,059us-gaap_StockholdersEquity 37,211us-gaap_StockholdersEquity
Total liabilities and stockholders’ equity $ 56,291us-gaap_LiabilitiesAndStockholdersEquity $ 55,689us-gaap_LiabilitiesAndStockholdersEquity